Chronic Myeloid Leukemia Relapsing as Isolated Extramedullary Disease Presenting as a Cardiac Mass / 대한내과학회지
Korean Journal of Medicine
; : 159-162, 2016.
Article
in Ko
| WPRIM
| ID: wpr-65765
Responsible library:
WPRO
ABSTRACT
Allogeneic hematopoietic stem cell transplantation is the only option for chemotherapy-refractory chronic myeloid leukemia (CML). Extramedullary relapse after transplantation is rare and usually accompanies marrow relapse. Generally, the prognosis of extramedullary relapse is poor. Here, we report a man with extramedullary relapsed CML after stem cell transplantation that presented as an isolated cardiac mass, which has shown an indolent course for more than 2 years, without evolving to medullary relapse during that period. This case implies that the CML clone might contribute to the development of quiescent extramedullary relapse with a benign course.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Prognosis
/
Recurrence
/
Bone Marrow
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Clone Cells
/
Hematopoietic Stem Cell Transplantation
/
Sarcoma, Myeloid
/
Stem Cell Transplantation
/
Heart Neoplasms
Type of study:
Prognostic_studies
Language:
Ko
Journal:
Korean Journal of Medicine
Year:
2016
Type:
Article